We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




In Vitro Technique Details Cancer Cell Attachment and Spread

By LabMedica International staff writers
Posted on 02 Oct 2018
Print article
Image: Fluorescence images of pancreatic cancer microtumors following overnight culture. Papillary structures pile up on micro-attachment sites (diameter 30 micrometers), with numerous cells visible per patch. The rightmost microtumor has extended over two attachment sites. Nuclei, actin filaments, and microtubules are labeled with blue, green, and red fluorescent markers, respectively (Photo courtesy of Miyatake Y. et al., Scientific Reports, September 19, 2018).
Image: Fluorescence images of pancreatic cancer microtumors following overnight culture. Papillary structures pile up on micro-attachment sites (diameter 30 micrometers), with numerous cells visible per patch. The rightmost microtumor has extended over two attachment sites. Nuclei, actin filaments, and microtubules are labeled with blue, green, and red fluorescent markers, respectively (Photo courtesy of Miyatake Y. et al., Scientific Reports, September 19, 2018).
A team of Japanese cell biologists described the development of a simple live-tumor in vitro imaging technique that enabled the study of the processes involved in the growth and spread of pancreatic cancer.

Investigators at Hokkaido University (Japan) reported in the September 19, 2018, online edition of the journal Scientific Reports that they had invented a new cell culture substrate comprising a coated nanoscale glass slide with etched islands of 30 micrometers in diameter, which allowed dynamic visualization of pancreatic ductal adenocarcinoma (PDAC) microtumors.

The investigators reported that when PDAC cells were cultured on the etched slides overnight, the cells self-organized into non-spheroidal microtumors that were anchored to the surface through cell-in-cell invasion (entosis). Using a time-lapse imaging system, they found that PDAC microtumors actively stretched to catch dead cell debris via filipodia (hair-like projections similar to those used for locomotion by some amoebas) and lamellipodia (cytoskeletal actin projections on the mobile edge of the cell).

The etched microplate method enabled visualization of live tumor dynamics; the microtumors endocytosed debris-derived surface nucleosides directly into vacuoles and then accumulated dead cell-derived phosphatidylserine (PS) on their surfaces (resulting in PS externalization, a cause of cancer immune evasion).

"Cancer studies so far either use cell cultures in which cancer cells do not necessarily behave naturally, or tissue samples that do not allow live observation. So there is a big gap in our knowledge of how cancer cells actually behave," said first author Dr. Yukiko Miyatake, assistant professor of pathology at Hokkaido University. "I hope this easy and low-cost technique will find widespread adoption. If the discoveries made during these first observations are physiologically or pathologically relevant phenomena, many more new hints may be gleaned for the development of more effective cancer treatment approaches."

Related Links:
Hokkaido University

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.